Skip to main content
. 2020 Aug 18;10:13944. doi: 10.1038/s41598-020-70669-9

Figure 4.

Figure 4

Urinary LAM is present at detectable concentrations in extrapulmonary adult TB patients and in microbiologically confirmed pediatric TB patients. (A) Levels of urinary LAM as measured using MoAb1 are significantly higher in extrapulmonary patients with respect to pulmonary patients. (B) MoAb1 is superior in discriminating extrapulmonary patients from non TB controls. (C) Levels of urinary LAM measured using CS35 are lower in TB positive pediatric patients than in TB positive adults. (D) ROC analysis demonstrated that MoAb1 was superior to the other antibodies in discriminating pediatric TB patients from negative controls.